Zenflow raises $52m for BPH implant and inks US distribution pact with Cook Medical
Zenflow’s Spring implant, designed to treat the symptoms of benign prostatic hyperplasia (BPH), secured FDA clearance in December 2025.
Zenflow’s Spring implant, designed to treat the symptoms of benign prostatic hyperplasia (BPH), secured FDA clearance in December 2025.
Surging demand for injectable therapies (led by GLP‑1s) is exposing a new constraint in drug delivery: not innovation, but the ability to industrialise and manufacture devices at scale.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Australia starts investigation into OpenAI Medicare breach
Industry partnership will determine the success of the transition to low-GWP pMDIs
UK government champions healthtech through new NHS access programme
Intuitive Surgical expands platforms despite market headwind